166 related articles for article (PubMed ID: 38700656)
1. Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron-results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP).
Hopff SM; Appel KS; Miljukov O; Schneider J; Addo MM; Bals R; Bercker S; Blaschke S; Bröhl I; Büchner N; Dashti H; Erber J; Friedrichs A; Geisler R; Göpel S; Hagen M; Hanses F; Jensen BO; Keul M; Krawczyk A; Lorenz-Depiereux B; Meybohm P; Milovanovic M; Mitrov L; Nürnberger C; Obst W; Römmele C; Schäfer C; Scheer C; Scherer M; Schmidt J; Seibel K; Sikdar S; Tebbe JJ; Tepasse PR; Thelen P; Vehreschild MJGT; Weismantel C; Vehreschild JJ
Infection; 2024 May; ():. PubMed ID: 38700656
[TBL] [Abstract][Full Text] [Related]
2. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON).
Appel KS; Nürnberger C; Bahmer T; Förster C; Polidori MC; Kohls M; Kraus T; Hettich-Damm N; Petersen J; Blaschke S; Bröhl I; Butzmann J; Dashti H; Deckert J; Dreher M; Fiedler K; Finke C; Geisler R; Hanses F; Hopff SM; Jensen BO; Konik M; Lehnert K; de Miranda SMN; Mitrov L; Miljukov O; Reese JP; Rohde G; Scherer M; Tausche K; Tebbe JJ; Vehreschild JJ; Voit F; Wagner P; Weigl M; Lemhöfer C;
Infection; 2024 Apr; ():. PubMed ID: 38587752
[TBL] [Abstract][Full Text] [Related]
3. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population.
Thi Khanh HN; Cornelissen L; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
BMC Infect Dis; 2023 Nov; 23(1):774. PubMed ID: 37940843
[TBL] [Abstract][Full Text] [Related]
4. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
Ballouz T; Menges D; Kaufmann M; Amati R; Frei A; von Wyl V; Fehr JS; Albanese E; Puhan MA
PLoS One; 2023; 18(2):e0281429. PubMed ID: 36812215
[TBL] [Abstract][Full Text] [Related]
5. Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
Gottlieb M; Wang RC; Yu H; Spatz ES; Montoy JCC; Rodriguez RM; Chang AM; Elmore JG; Hannikainen PA; Hill M; Huebinger RM; Idris AH; Lin Z; Koo K; McDonald S; O'Laughlin KN; Plumb ID; Santangelo M; Saydah S; Willis M; Wisk LE; Venkatesh A; Stephens KA; Weinstein RA;
Clin Infect Dis; 2023 Jun; 76(11):1930-1941. PubMed ID: 36705268
[TBL] [Abstract][Full Text] [Related]
6. Post COVID-19 condition and health-related quality of life: a longitudinal cohort study in the Belgian adult population.
Smith P; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Cornelissen L; Devleesschauwer B; De Ridder K; Charafeddine R
BMC Public Health; 2023 Jul; 23(1):1433. PubMed ID: 37495947
[TBL] [Abstract][Full Text] [Related]
7. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
[TBL] [Abstract][Full Text] [Related]
8. Lower prevalence of post-Covid-19 Condition following Omicron SARS-CoV-2 infection.
de Bruijn S; van Hoek AJ; Mutubuki EN; Knoop H; Slootweg J; Tulen AD; Franz E; van den Wijngaard CC; van der Maaden T
Heliyon; 2024 Apr; 10(7):e28941. PubMed ID: 38617937
[TBL] [Abstract][Full Text] [Related]
9. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study.
Bahmer T; Borzikowsky C; Lieb W; Horn A; Krist L; Fricke J; Scheibenbogen C; Rabe KF; Maetzler W; Maetzler C; Laudien M; Frank D; Ballhausen S; Hermes A; Miljukov O; Haeusler KG; Mokhtari NEE; Witzenrath M; Vehreschild JJ; Krefting D; Pape D; Montellano FA; Kohls M; Morbach C; Störk S; Reese JP; Keil T; Heuschmann P; Krawczak M; Schreiber S;
EClinicalMedicine; 2022 Sep; 51():101549. PubMed ID: 35875815
[TBL] [Abstract][Full Text] [Related]
10. Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.
Doll MK; Waghmare A; Heit A; Levenson Shakoor B; Kimball LE; Ozbek N; Blazevic RL; Mose L; Boonyaratanakornkit J; Stevens-Ayers TL; Cornell K; Sheppard BD; Hampson E; Sharmin F; Goodwin B; Dan JM; Archie T; O'Connor T; Heckerman D; Schmitz F; Boeckh M; Crotty S
JAMA Netw Open; 2023 Feb; 6(2):e231181. PubMed ID: 36853602
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
[TBL] [Abstract][Full Text] [Related]
12. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
Menni C; Valdes AM; Polidori L; Antonelli M; Penamakuri S; Nogal A; Louca P; May A; Figueiredo JC; Hu C; Molteni E; Canas L; Österdahl MF; Modat M; Sudre CH; Fox B; Hammers A; Wolf J; Capdevila J; Chan AT; David SP; Steves CJ; Ourselin S; Spector TD
Lancet; 2022 Apr; 399(10335):1618-1624. PubMed ID: 35397851
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study.
Stock SJ; Moore E; Calvert C; Carruthers J; Denny C; Donaghy J; Hillman S; Hopcroft LEM; Hopkins L; Goulding A; Lindsay L; McLaughlin T; Taylor B; Auyeung B; Katikireddi SV; McCowan C; Ritchie LD; Rudan I; Simpson CR; Robertson C; Sheikh A; Wood R
Lancet Respir Med; 2022 Dec; 10(12):1129-1136. PubMed ID: 36216011
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study.
Yildirim Arslan S; Avcu G; Sahbudak Bal Z; Arslan A; Ozkinay FF; Kurugol Z
Eur J Pediatr; 2023 Oct; 182(10):4565-4571. PubMed ID: 37526704
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
Townsley H; Gahir J; Russell TW; Greenwood D; Carr EJ; Dyke M; Adams L; Miah M; Clayton B; Smith C; Miranda M; Mears HV; Bailey C; Black JRM; Fowler AS; Crawford M; Wilkinson K; Hutchinson M; Harvey R; O'Reilly N; Kelly G; Goldstone R; Beale R; Papineni P; Corrah T; Gilson R; Caidan S; Nicod J; Gamblin S; Kassiotis G; Libri V; Williams B; Gandhi S; Kucharski AJ; Swanton C; Bauer DLV; Wall EC
PLoS One; 2024; 19(3):e0294897. PubMed ID: 38512960
[TBL] [Abstract][Full Text] [Related]
17. The Burden and Characteristics of Post-COVID-19 Conditions Among Laboratory-Confirmed Delta and Omicron COVID-19 Cases: A Preliminary Study From Maharashtra, India.
Karyakarte RP; Das R; Rajmane MV; Dudhate S; Agarasen J; Pillai P; Chandankhede PM; Labhshetwar RS; Gadiyal Y; Kulkarni PP; Nizarudeen S; Mukade S; Joshi S
Cureus; 2023 Sep; 15(9):e44888. PubMed ID: 37814744
[TBL] [Abstract][Full Text] [Related]
18. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
19. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
[TBL] [Abstract][Full Text] [Related]
20. Association between virus variants, vaccination, previous infections, and post-COVID-19 risk.
Diexer S; Klee B; Gottschick C; Xu C; Broda A; Purschke O; Binder M; Frese T; Girndt M; Hoell JI; Moor I; Gekle M; Mikolajczyk R
Int J Infect Dis; 2023 Nov; 136():14-21. PubMed ID: 37634619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
